Skip to content
  • Saturday, 15 August 2026
  • 12:15 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • A decade in the making: How functional NAMs are redefining cardiac safety assessment
Laboratory Automation & Robotics

A decade in the making: How functional NAMs are redefining cardiac safety assessment

Lana Keisha Jun 20, 2026 0

In recent years, the pharmaceutical industry has witnessed a dramatic acceleration in the adoption of New Approach Methodologies (NAMs) for…

Read More
Laboratory Automation & Robotics

A decade in the making: How functional NAMs are redefining cardiac safety assessment

Lana Keisha May 31, 2026 0

The rapid acceleration in the adoption of New Approach Methodologies (NAMs) for drug safety testing, often perceived as a sudden…

Read More
Laboratory Automation & Robotics

A decade in the making: How functional NAMs are redefining cardiac safety assessment

Lana Keisha May 21, 2026 0

The landscape of drug safety testing is undergoing a profound transformation, marked by the rapid ascent of New Approach Methodologies…

Read More
Laboratory Automation & Robotics

A decade in the making: How functional NAMs are redefining cardiac safety assessment

Lana Keisha May 14, 2026 0

In recent years, the landscape of drug safety testing has undergone a profound transformation, marked by the rapid acceleration of…

Read More
Laboratory Automation & Robotics

A decade in the making: How functional NAMs are redefining cardiac safety assessment

Lana Keisha May 7, 2026 0

The rapid acceleration of New Approach Methodologies (NAMs) in drug safety testing has, for many, appeared to be a sudden…

Read More
Stop Using If-Else Chains: Use the Registry Pattern in Python InsteadResearchers Develop High-Efficiency Additive Manufacturing Technique for Tungsten Carbide-Cobalt Using Hot-Wire Laser IrradiationThe ‘forever drug’ assumption about GLP-1s may be wrong, according to nference analysisTWiV 1293: The enemy of your parasite is your friend
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactLLMOps in 2026: The 10 Tools Every Team Must HaveThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ